Ann: US FDA Completes Review of IHL-42x IND Application, page-6

Great News. I think 2-3 weeks for trial to start regarding IRB application and site selection. But for sure this will attract big investor, it might not today but in coming day will happen once we move to NASDAQ.

"The overall success rate of drugs moving from Phase 2 clinical trials to FDA approval was approximately 33.4%. This means that roughly one out of every three drugs that complete Phase 2 trials will ultimately be approved by the FDA, and how progression through the phases can de-risk investors and companies. The success rate for FDA approval increases further to 58.1% upon completion of Phase 3 clinical trials according to BIO. "

Overall success increases with phase 2/3 trial . We hope to have great SP appreciation going forward.